电邮这篇文章 Quantitative assessment of protein replacement in therapeutic plasmapheresis
- 作者: Kalinin NN1, Movshev ВЕ1, Hester D1, Petrova VI1
-
隶属关系:
- 期: 卷 78, 编号 2 (2003)
- 页面: 65-68
- 栏目: Editorial
- ##submission.dateSubmitted##: 09.04.2020
- ##submission.datePublished##: 15.02.2003
- URL: https://ter-arkhiv.ru/0040-3660/article/view/29319
- ID: 29319
如何引用文章
全文:
详细
Aim. To calculate parameters of replacement in which the amount of total protein (TP) in the circulating blood remains above critical level after removal of 17-75% of circulating plasm volume (CPL). Material and methods. Therapeutic plasmapheresis (TPA) was made in 96 patients with rheumatoid arthritis, bronchial asthma, systemic lupus erythematosus and other diseases. The plasm was replaced by 0.9% sodium chloride solution, rheopolyglucine and albumin solutions in isovolemic regime. Albumin was given in quantities equivalent to 50-65% of the removed protein.
Results. Close correlation was observed between the expected and actual concentrations of total protein in 96 patients who have undergone 206 TPA procedures. In removal of up to 35% CPL protein deficiency is compensated by its mobilization from the deposits and due to protein-synthetizing function of the liver. In removal of 75% and more and in initial hypoproteinemia 50% of the protein should be replaced. Conclusion. It is confirmed that rheopolyglucin can be used for plasm replacement in TPA in patients with hyperproteinemia having no contraindications.
Results. Close correlation was observed between the expected and actual concentrations of total protein in 96 patients who have undergone 206 TPA procedures. In removal of up to 35% CPL protein deficiency is compensated by its mobilization from the deposits and due to protein-synthetizing function of the liver. In removal of 75% and more and in initial hypoproteinemia 50% of the protein should be replaced. Conclusion. It is confirmed that rheopolyglucin can be used for plasm replacement in TPA in patients with hyperproteinemia having no contraindications.
参考
- Калинин Н. Н., Хестер Д. Методы непрерывнопоточного центрифугирования. Гематол. и трансфузиол. 1985; 1: 53-55.
- Kellogg R., Hester J. Kinetics modeling of plasma exchange: intra- and post-plasma exchange. J. Clin. Apheres. 1988: 4(4): 183-187.
- Мовшев Б. Е., Маркова М. Л., Калинин Н. Н. и др. Бел ко во-волемические показатели при умеренном плазмаферс зе. Гематол. и трансфузиол. 1989; 12: 12-17.
- Серафимов-Димшпров В. Трофоплазмон. В кн.: Серафимов-Димитров В. (ред.) Трансфузионная гематология. Со фия: медицина и спорт; 1974. 84-90.
- Bujfaloe С., Heineken F. Plasma volume nomograms for use ii therapeutic plasma exchange. Transfusion 1983; 23: 355-357.
- Huestis D. Therapeutic application of hemapheresis. In: Casl J. D., ed. Progress in transfusion medicine. Edinburgh Churchill Inc.; 1986. 78-94.
- Соколов С. С., Постников А. А. Методические подходы у определению объема удаляемой плазмы при интенсивной лечебном плазмаферезе. Гематол. и трансфузиол. 1987; 11 55-57.
- Gurland H., Samtleben W., Blumenstein M. Therapeutic plasmapheresis: present state and future aspects. Life Support Syst. 1983; 1: 61-70.
- Lundsgaard-Hansen P., Tschirren B. Die Verwendung von Plasmaersatzmittein un Albumin in Rnhmen der Komponententhetapie. In: Klinische. Anaesthesiologie. Intensivetherapil Berlin: Springer; 1980. 120-135.
- Lasky L., Finnevty E., Genis L. et al. Protein and colloid osmotic presstire changes with albumin and/or saline replacement during plasma exchange. Transfusion 1984; 24: 256-259.
- Guyton A. Capillary dynamics and exchange of fluid between the blood and interstitial fluid. In: Guyton A, ed. Textbook of medical physiology. 6"' ed. Philadelphia: W. B. Saunders Co; 1981. 358-369.
- McEvoy G. K. American hospital formulary service drug information. Bethesda, Maryland: American Society of Health System Parmacists. 1996. 1864-1865.
补充文件
